ArticleOpen forum infectious diseases2026
Mind the Gap: Inadequate Performance of Embolic Risk Scores in Infective Endocarditis.
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Embolic events (EEs) are frequent and clinically important complications of infective endocarditis (IE). Three scores have been developed to predict EEs: the Methods: This is a multicenter retrospective study including adult patients diagnosed with IE between 2014 and 2024 at Lausanne University Hospital and University Hospital Zurich. Embolic events and IE were defined according to the 2023 International Society of Cardiovascular Infectious Diseases (ISCVID) Duke criteria. Scores were applied according to their respective populations, and performance was evaluated using sensitivity, specificity, and accuracy. Results: Among 1331 IE episodes, 674 (51%) experienced EEs, with 474 (36%) before and 348 (26%) after antimicrobial initiation. The Embolic Risk French Calculator, applied to 1201 valve-related IE episodes, identified 358 (30%) as high risk. Accuracy for predicting postantibiotic EEs was 66% (95% CI 64%-69%). The Italian Endocarditis Study score, applied to 1073 episodes with left-side IE, classified 563 (53%) as intermediate/high risk, with an overall accuracy of 60% (56%-62%). The University of Campania score, applied to 701 valve-related IE episodes, identified 341 (49%) as intermediate/high risk, with an accuracy of 63% (60%-67%). Conclusions: All 3 scores demonstrated limited predictive accuracy and frequently misclassified patients. More robust tools are needed to guide embolic risk stratification in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.